Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer

Bahir Aldulaymi; Ib J Christensen; György Sölétormos; Per Jess; Svend Erik Nielsen; Nils Brünner; Hans J Nielsen

Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer

Bahir Aldulaymi, Ib J Christensen, György Sölétormos, Per Jess, Svend Erik Nielsen, Nils Brünner, Hans J Nielsen

14 Citationer (Scopus)

Abstract

Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been suggested to be a valuable marker in colorectal cancer (CRC), but the effects of chemotherapy on TIMP-1 levels are unknown. The present study evaluated the effect of chemotherapy on TIMP-1 levels in comparison with carcinoembryonic antigen (CEA) levels in patients with stage III colon cancer.

Originalsprog	Engelsk
Tidsskrift	Anticancer Research
Vol/bind	30
Udgave nummer	1
Sider (fra-til)	233-7
Antal sider	5
ISSN	0250-7005
Status	Udgivet - 1 jan. 2010

Adgang til dokumentet

http://www.ncbi.nlm.nih.gov/pubmed?term=Changes%20in%20soluble%20CEA%20and%20TIMP-1%20levels%20during%20adjuvant%20chemotherapy%20for%20stage%20III%20colon%20cancer

Citationsformater

Aldulaymi, B., Christensen, I. J., Sölétormos, G., Jess, P., Nielsen, S. E., Brünner, N., & Nielsen, H. J. (2010). Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer. Anticancer Research, 30(1), 233-7. http://www.ncbi.nlm.nih.gov/pubmed?term=Changes%20in%20soluble%20CEA%20and%20TIMP-1%20levels%20during%20adjuvant%20chemotherapy%20for%20stage%20III%20colon%20cancer

Aldulaymi, B, Christensen, IJ, Sölétormos, G, Jess, P, Nielsen, SE, Brünner, N & Nielsen, HJ 2010, 'Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer', Anticancer Research, bind 30, nr. 1, s. 233-7. <http://www.ncbi.nlm.nih.gov/pubmed?term=Changes%20in%20soluble%20CEA%20and%20TIMP-1%20levels%20during%20adjuvant%20chemotherapy%20for%20stage%20III%20colon%20cancer>

@article{e6107c5b836541aca95dd792d0d1fa18,

title = "Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer",

abstract = "Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been suggested to be a valuable marker in colorectal cancer (CRC), but the effects of chemotherapy on TIMP-1 levels are unknown. The present study evaluated the effect of chemotherapy on TIMP-1 levels in comparison with carcinoembryonic antigen (CEA) levels in patients with stage III colon cancer.",

author = "Bahir Aldulaymi and Christensen, {Ib J} and Gy{\"o}rgy S{\"o}l{\'e}tormos and Per Jess and Nielsen, {Svend Erik} and Nils Br{\"u}nner and Nielsen, {Hans J}",

year = "2010",

month = jan,

day = "1",

language = "English",

volume = "30",

pages = "233--7",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "1",

}

TY - JOUR

T1 - Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer

AU - Aldulaymi, Bahir

AU - Christensen, Ib J

AU - Sölétormos, György

AU - Jess, Per

AU - Nielsen, Svend Erik

AU - Brünner, Nils

AU - Nielsen, Hans J

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been suggested to be a valuable marker in colorectal cancer (CRC), but the effects of chemotherapy on TIMP-1 levels are unknown. The present study evaluated the effect of chemotherapy on TIMP-1 levels in comparison with carcinoembryonic antigen (CEA) levels in patients with stage III colon cancer.

AB - Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been suggested to be a valuable marker in colorectal cancer (CRC), but the effects of chemotherapy on TIMP-1 levels are unknown. The present study evaluated the effect of chemotherapy on TIMP-1 levels in comparison with carcinoembryonic antigen (CEA) levels in patients with stage III colon cancer.

M3 - Journal article

C2 - 20150641

SN - 0250-7005

VL - 30

SP - 233

EP - 237

JO - Anticancer Research

JF - Anticancer Research

IS - 1

ER -

Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater